| Jennifer Kay Chace, MSAPRN | |
|
1011 Veterans Memorial Pkwy, East Providence, RI 02915-5061 | |
| (401) 432-1359 | |
| (401) 432-1500 |
| Full Name | Jennifer Kay Chace |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent |
| Location | 1011 Veterans Memorial Pkwy, East Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841235470 | NPI | - | NPPES |
| 410333 | Other | RI | BLUE CHIP |
| 21495-5 | Other | RI | BLUE CROSS |
| JC47154 | Medicaid | RI | |
| 211412 | Other | RI | UNITED BEHAVIORAL HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0807X | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent | PPNS00067 (Rhode Island) | Primary |
| Entity Name | Kerzner Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003912049 PECOS PAC ID: 7012957541 Enrollment ID: O20070501000031 |
News Archive
Building on its worldwide reputation as a leader in neuroscience research, McGill University today joined with two leading Swiss research institutions - the University of Zurich (UZH) and the Swiss Federal Institute of Technology (ETHZ) - to enhance neuroscience research in a host of areas, in fields that include pain therapy, Alzheimer's disease, synapse modelling and repair, neuroimmunology and genetic mechanisms of brain diseases.
PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.
Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart AEDs at U.S. Postal Inspection Service sites across the nation.
Providing a valuable incentive for U.S. investment in Australia, the Australian Government announced an agreement under which the Parliament will enact a AU$1.8 billion R&D tax credit that will deliver funding to innovative firms in industries including advanced manufacturing, information and communications technologies, and biotechnology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Kay Chace, MSAPRN 1011 Veterans Memorial Pkwy, Riverside, RI 02915-5061 Ph: (401) 432-1359 | Jennifer Kay Chace, MSAPRN 1011 Veterans Memorial Pkwy, East Providence, RI 02915-5061 Ph: (401) 432-1359 |
News Archive
Building on its worldwide reputation as a leader in neuroscience research, McGill University today joined with two leading Swiss research institutions - the University of Zurich (UZH) and the Swiss Federal Institute of Technology (ETHZ) - to enhance neuroscience research in a host of areas, in fields that include pain therapy, Alzheimer's disease, synapse modelling and repair, neuroimmunology and genetic mechanisms of brain diseases.
PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.
Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart AEDs at U.S. Postal Inspection Service sites across the nation.
Providing a valuable incentive for U.S. investment in Australia, the Australian Government announced an agreement under which the Parliament will enact a AU$1.8 billion R&D tax credit that will deliver funding to innovative firms in industries including advanced manufacturing, information and communications technologies, and biotechnology.
› Verified 9 days ago
Elizabeth A. Sherman, APRN, PMHNP-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 400 Massasoit Ave Ste 305, East Providence, RI 02914 Phone: 401-294-0451 Fax: 401-294-0461 |